Srishti Rawat - Publications
Affiliations: | 2015-2020 | University of Delhi |
Year | Citation | Score | |||
---|---|---|---|---|---|
2022 | Singh P, Rawat S, Agrahari AK, Singh M, Chugh S, Gurcha S, Singh A, Abrahams K, Besra GS, Asthana S, Rawat DS, Singh R. NSC19723, a Thiacetazone-Like Benzaldehyde Thiosemicarbazone Improves the Efficacy of TB Drugs and . Microbiology Spectrum. e0259222. PMID 36314972 DOI: 10.1128/spectrum.02592-22 | 0.52 | |||
2021 | Paul A, Anand R, Karmakar SP, Rawat S, Bairagi N, Chatterjee S. Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models. Scientific Reports. 11: 213. PMID 33420254 DOI: 10.1038/s41598-020-80561-1 | 0.309 | |||
2021 | Bahuguna A, Rawat S, Rawat DS. QcrB in Mycobacterium tuberculosis: The new drug target of antitubercular agents. Medicinal Research Reviews. PMID 33400275 DOI: 10.1002/med.21779 | 0.366 | |||
2020 | Vaidya FU, Sufiyan Chhipa A, Mishra V, Gupta VK, Rawat SG, Kumar A, Pathak C. Molecular and cellular paradigms of multidrug resistance in cancer. Cancer Reports (Hoboken, N.J.). e1291. PMID 33052041 DOI: 10.1002/cnr2.1291 | 0.324 | |||
2020 | Arora N, Raj A, Anjum F, Kaur R, Rawat SS, Kumar R, Tripathi S, Singh G, Prasad A. Unveiling kinome profile and its potential for new therapeutic targets. Expert Review of Proteomics. PMID 31968176 DOI: 10.1080/14789450.2020.1719835 | 0.377 | |||
Show low-probability matches. |